IRulya Therapeutics paid its 3 named executives $4.9M in total in FY2025 (Dec). CEO Dirk Thye was paid $2.5M of that.
Pay$100 in the stock at the end of FY21 → $27
Pay of each named executive
Dirk ThyeChief Executive Officer and Chief Medical Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Brendan HannahChief Operating Officer, Chief Business Officer and Chief Compliance Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Charles RyanPresident
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.